Genetic Polymorphism of Mismatch Repair Genes and Susceptibility to Prostate Cancer
Mismatch repair (MMR) is one of the DNA repair systems that correct mispaired bases during DNA replication errors. Polymorphisms in genes can increase susceptibility to the development of prostate cancer (PCa). In this study, we investigated mutL homolog 1 (MLH1) -93G>A (rs1800734) and mutS homol...
Gespeichert in:
Veröffentlicht in: | Urology journal 2020-05, Vol.17 (3), p.271 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 3 |
container_start_page | 271 |
container_title | Urology journal |
container_volume | 17 |
creator | Khooshemehri, Paniz Jamaldini, Seyed Hamid Ziaee, Seyed Amir Mohsen Afshari, Mahdi Sattari, Mahshid Narouie, Behzad Sotoudeh, Mehdi Montazeri, Vahideh Sarhangi, Negar Hasanzad, Mandana |
description | Mismatch repair (MMR) is one of the DNA repair systems that correct mispaired bases during DNA replication errors. Polymorphisms in genes can increase susceptibility to the development of prostate cancer (PCa). In this study, we investigated mutL homolog 1 (MLH1) -93G>A (rs1800734) and mutS homolog 3 (MSH3) (rs26279) polymorphisms with the risk of PCa.
In this study of Iranian population, 175 histopathologically confirmed (PCa) patients and 230 benign prostate hyperplasia (BPH) as the controls were recruited. The genotypes of MLH1 and MSH3 were determined by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) method.
There was no significant difference of MLH1 (P = 0.4) and MSH3 (P?=?0.5) genotype distributions among PCa cases and controls. And also patients with PCa were not significant differences compared to those without in stage of cancer, grade of tumor, perineural invasion, and vascular invasion.
Our results did not show adequate evidence for any significant association of MLH1 and MSH3 polymorphisms and PCa . |
doi_str_mv | 10.22037/uj.v0i0.5051 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_2819508596</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2819508596</sourcerecordid><originalsourceid>FETCH-LOGICAL-p239t-3c35a86869098b4ada364a68ff7d6206f17d864d0b772362fd94c534a6dbe11f3</originalsourceid><addsrcrecordid>eNo10MFLwzAUBvAgipvTo1cJeO5M8po0PcrQKUwcTsFbSZuEZaxNTVJh_70V5-l7hx_f4z2ErimZM0aguBt282_iyJwTTk_QlBbAM56Lz9PjTIHICbqIcUdGAUScownQkoMEPkWbpelMcg1e-_2h9aHfuthib_HLmCo1W_xmeuUC_nURq07jzRAb0ydXu71LB5w8Xgcfk0oGL1TXmHCJzqzaR3N1zBn6eHx4Xzxlq9fl8-J-lfUMypRBA1xJIUVJSlnnSisQuRLS2kILRoSlhZYi16QuCgaCWV3mDYeR6NpQamGGbv96--C_BhNTtfND6MaVFZPjhUTyUozq5qiGujW66oNrVThU_z-AH2cbXcQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2819508596</pqid></control><display><type>article</type><title>Genetic Polymorphism of Mismatch Repair Genes and Susceptibility to Prostate Cancer</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Khooshemehri, Paniz ; Jamaldini, Seyed Hamid ; Ziaee, Seyed Amir Mohsen ; Afshari, Mahdi ; Sattari, Mahshid ; Narouie, Behzad ; Sotoudeh, Mehdi ; Montazeri, Vahideh ; Sarhangi, Negar ; Hasanzad, Mandana</creator><creatorcontrib>Khooshemehri, Paniz ; Jamaldini, Seyed Hamid ; Ziaee, Seyed Amir Mohsen ; Afshari, Mahdi ; Sattari, Mahshid ; Narouie, Behzad ; Sotoudeh, Mehdi ; Montazeri, Vahideh ; Sarhangi, Negar ; Hasanzad, Mandana</creatorcontrib><description>Mismatch repair (MMR) is one of the DNA repair systems that correct mispaired bases during DNA replication errors. Polymorphisms in genes can increase susceptibility to the development of prostate cancer (PCa). In this study, we investigated mutL homolog 1 (MLH1) -93G>A (rs1800734) and mutS homolog 3 (MSH3) (rs26279) polymorphisms with the risk of PCa.
In this study of Iranian population, 175 histopathologically confirmed (PCa) patients and 230 benign prostate hyperplasia (BPH) as the controls were recruited. The genotypes of MLH1 and MSH3 were determined by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) method.
There was no significant difference of MLH1 (P = 0.4) and MSH3 (P?=?0.5) genotype distributions among PCa cases and controls. And also patients with PCa were not significant differences compared to those without in stage of cancer, grade of tumor, perineural invasion, and vascular invasion.
Our results did not show adequate evidence for any significant association of MLH1 and MSH3 polymorphisms and PCa .</description><identifier>ISSN: 1735-1308</identifier><identifier>EISSN: 1735-546X</identifier><identifier>DOI: 10.22037/uj.v0i0.5051</identifier><identifier>PMID: 31953835</identifier><language>eng</language><publisher>Iran: Urology and Nephrology Research Center</publisher><subject>Aged ; Case-Control Studies ; DNA Mismatch Repair ; Genetic Predisposition to Disease ; Humans ; Iran ; Male ; Middle Aged ; MutL Protein Homolog 1 - genetics ; MutS Homolog 3 Protein - genetics ; Polymorphism ; Polymorphism, Restriction Fragment Length ; Prostate cancer ; Prostatic Neoplasms - genetics ; Yeast</subject><ispartof>Urology journal, 2020-05, Vol.17 (3), p.271</ispartof><rights>Copyright Urology and Nephrology Research Center May-Jun 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31953835$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Khooshemehri, Paniz</creatorcontrib><creatorcontrib>Jamaldini, Seyed Hamid</creatorcontrib><creatorcontrib>Ziaee, Seyed Amir Mohsen</creatorcontrib><creatorcontrib>Afshari, Mahdi</creatorcontrib><creatorcontrib>Sattari, Mahshid</creatorcontrib><creatorcontrib>Narouie, Behzad</creatorcontrib><creatorcontrib>Sotoudeh, Mehdi</creatorcontrib><creatorcontrib>Montazeri, Vahideh</creatorcontrib><creatorcontrib>Sarhangi, Negar</creatorcontrib><creatorcontrib>Hasanzad, Mandana</creatorcontrib><title>Genetic Polymorphism of Mismatch Repair Genes and Susceptibility to Prostate Cancer</title><title>Urology journal</title><addtitle>Urol J</addtitle><description>Mismatch repair (MMR) is one of the DNA repair systems that correct mispaired bases during DNA replication errors. Polymorphisms in genes can increase susceptibility to the development of prostate cancer (PCa). In this study, we investigated mutL homolog 1 (MLH1) -93G>A (rs1800734) and mutS homolog 3 (MSH3) (rs26279) polymorphisms with the risk of PCa.
In this study of Iranian population, 175 histopathologically confirmed (PCa) patients and 230 benign prostate hyperplasia (BPH) as the controls were recruited. The genotypes of MLH1 and MSH3 were determined by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) method.
There was no significant difference of MLH1 (P = 0.4) and MSH3 (P?=?0.5) genotype distributions among PCa cases and controls. And also patients with PCa were not significant differences compared to those without in stage of cancer, grade of tumor, perineural invasion, and vascular invasion.
Our results did not show adequate evidence for any significant association of MLH1 and MSH3 polymorphisms and PCa .</description><subject>Aged</subject><subject>Case-Control Studies</subject><subject>DNA Mismatch Repair</subject><subject>Genetic Predisposition to Disease</subject><subject>Humans</subject><subject>Iran</subject><subject>Male</subject><subject>Middle Aged</subject><subject>MutL Protein Homolog 1 - genetics</subject><subject>MutS Homolog 3 Protein - genetics</subject><subject>Polymorphism</subject><subject>Polymorphism, Restriction Fragment Length</subject><subject>Prostate cancer</subject><subject>Prostatic Neoplasms - genetics</subject><subject>Yeast</subject><issn>1735-1308</issn><issn>1735-546X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNo10MFLwzAUBvAgipvTo1cJeO5M8po0PcrQKUwcTsFbSZuEZaxNTVJh_70V5-l7hx_f4z2ErimZM0aguBt282_iyJwTTk_QlBbAM56Lz9PjTIHICbqIcUdGAUScownQkoMEPkWbpelMcg1e-_2h9aHfuthib_HLmCo1W_xmeuUC_nURq07jzRAb0ydXu71LB5w8Xgcfk0oGL1TXmHCJzqzaR3N1zBn6eHx4Xzxlq9fl8-J-lfUMypRBA1xJIUVJSlnnSisQuRLS2kILRoSlhZYi16QuCgaCWV3mDYeR6NpQamGGbv96--C_BhNTtfND6MaVFZPjhUTyUozq5qiGujW66oNrVThU_z-AH2cbXcQ</recordid><startdate>20200501</startdate><enddate>20200501</enddate><creator>Khooshemehri, Paniz</creator><creator>Jamaldini, Seyed Hamid</creator><creator>Ziaee, Seyed Amir Mohsen</creator><creator>Afshari, Mahdi</creator><creator>Sattari, Mahshid</creator><creator>Narouie, Behzad</creator><creator>Sotoudeh, Mehdi</creator><creator>Montazeri, Vahideh</creator><creator>Sarhangi, Negar</creator><creator>Hasanzad, Mandana</creator><general>Urology and Nephrology Research Center</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20200501</creationdate><title>Genetic Polymorphism of Mismatch Repair Genes and Susceptibility to Prostate Cancer</title><author>Khooshemehri, Paniz ; Jamaldini, Seyed Hamid ; Ziaee, Seyed Amir Mohsen ; Afshari, Mahdi ; Sattari, Mahshid ; Narouie, Behzad ; Sotoudeh, Mehdi ; Montazeri, Vahideh ; Sarhangi, Negar ; Hasanzad, Mandana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p239t-3c35a86869098b4ada364a68ff7d6206f17d864d0b772362fd94c534a6dbe11f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Case-Control Studies</topic><topic>DNA Mismatch Repair</topic><topic>Genetic Predisposition to Disease</topic><topic>Humans</topic><topic>Iran</topic><topic>Male</topic><topic>Middle Aged</topic><topic>MutL Protein Homolog 1 - genetics</topic><topic>MutS Homolog 3 Protein - genetics</topic><topic>Polymorphism</topic><topic>Polymorphism, Restriction Fragment Length</topic><topic>Prostate cancer</topic><topic>Prostatic Neoplasms - genetics</topic><topic>Yeast</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khooshemehri, Paniz</creatorcontrib><creatorcontrib>Jamaldini, Seyed Hamid</creatorcontrib><creatorcontrib>Ziaee, Seyed Amir Mohsen</creatorcontrib><creatorcontrib>Afshari, Mahdi</creatorcontrib><creatorcontrib>Sattari, Mahshid</creatorcontrib><creatorcontrib>Narouie, Behzad</creatorcontrib><creatorcontrib>Sotoudeh, Mehdi</creatorcontrib><creatorcontrib>Montazeri, Vahideh</creatorcontrib><creatorcontrib>Sarhangi, Negar</creatorcontrib><creatorcontrib>Hasanzad, Mandana</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Urology journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khooshemehri, Paniz</au><au>Jamaldini, Seyed Hamid</au><au>Ziaee, Seyed Amir Mohsen</au><au>Afshari, Mahdi</au><au>Sattari, Mahshid</au><au>Narouie, Behzad</au><au>Sotoudeh, Mehdi</au><au>Montazeri, Vahideh</au><au>Sarhangi, Negar</au><au>Hasanzad, Mandana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genetic Polymorphism of Mismatch Repair Genes and Susceptibility to Prostate Cancer</atitle><jtitle>Urology journal</jtitle><addtitle>Urol J</addtitle><date>2020-05-01</date><risdate>2020</risdate><volume>17</volume><issue>3</issue><spage>271</spage><pages>271-</pages><issn>1735-1308</issn><eissn>1735-546X</eissn><abstract>Mismatch repair (MMR) is one of the DNA repair systems that correct mispaired bases during DNA replication errors. Polymorphisms in genes can increase susceptibility to the development of prostate cancer (PCa). In this study, we investigated mutL homolog 1 (MLH1) -93G>A (rs1800734) and mutS homolog 3 (MSH3) (rs26279) polymorphisms with the risk of PCa.
In this study of Iranian population, 175 histopathologically confirmed (PCa) patients and 230 benign prostate hyperplasia (BPH) as the controls were recruited. The genotypes of MLH1 and MSH3 were determined by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) method.
There was no significant difference of MLH1 (P = 0.4) and MSH3 (P?=?0.5) genotype distributions among PCa cases and controls. And also patients with PCa were not significant differences compared to those without in stage of cancer, grade of tumor, perineural invasion, and vascular invasion.
Our results did not show adequate evidence for any significant association of MLH1 and MSH3 polymorphisms and PCa .</abstract><cop>Iran</cop><pub>Urology and Nephrology Research Center</pub><pmid>31953835</pmid><doi>10.22037/uj.v0i0.5051</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1735-1308 |
ispartof | Urology journal, 2020-05, Vol.17 (3), p.271 |
issn | 1735-1308 1735-546X |
language | eng |
recordid | cdi_proquest_journals_2819508596 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
subjects | Aged Case-Control Studies DNA Mismatch Repair Genetic Predisposition to Disease Humans Iran Male Middle Aged MutL Protein Homolog 1 - genetics MutS Homolog 3 Protein - genetics Polymorphism Polymorphism, Restriction Fragment Length Prostate cancer Prostatic Neoplasms - genetics Yeast |
title | Genetic Polymorphism of Mismatch Repair Genes and Susceptibility to Prostate Cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T21%3A18%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genetic%20Polymorphism%20of%20Mismatch%20Repair%20Genes%20and%20Susceptibility%20to%20Prostate%20Cancer&rft.jtitle=Urology%20journal&rft.au=Khooshemehri,%20Paniz&rft.date=2020-05-01&rft.volume=17&rft.issue=3&rft.spage=271&rft.pages=271-&rft.issn=1735-1308&rft.eissn=1735-546X&rft_id=info:doi/10.22037/uj.v0i0.5051&rft_dat=%3Cproquest_pubme%3E2819508596%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2819508596&rft_id=info:pmid/31953835&rfr_iscdi=true |